ANALYST REPORTS ON COMPANIES ANNOUNCING GAME CHANGING DEVELOPMENTS

Burton, MI - October 02, 2014 - InvestorsHub NewsWire - Anavex Life Sciences Corp. (OTCQB: AVXL) is a clinical-stage biopharmaceutical company engaged in the development of novel drug candidates to treat Alzheimer's disease, other CNS diseases and various types of cancer.
The report that follows gives an update on the company’s flagship Alzheimer’s drug, ANAVEX 2-73 and gives information on a recent meeting of the Alzheimer’s Foundation: http://bit.ly/-AVXL-AnalystReport
Abbatis Bioceuticals, Corp. (OTCQX: ATTBF) Abattis is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America.
The company has added a new member to its Board of Directors and reported updates to its entry into the cannabis market space. Get all the details at this link: http://bit.ly/-ATTBF-AnalystReport
Xun Energy, Inc. (OTCBB: XNRG) is engaged in the acquisition of producing or near producing oil and gas properties and the development of these oil and gas properties. The Company plans to acquire producing or near producing oil and gas properties that will provide cash flow and an upside for future development.
The company is seeking additional financing. Read about the company’s fund raising efforts and what they will do with the funding in the report at this link: http://bit.ly/-XNRG-AnalystReport
ADM Tronics Unlimited, Inc. (OTCBB: ADMT) ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house.
The company has entered into an affiliation that has generated two subsidiaries. These subsidiaries can utilize the expertise and technology the company already has. Get the full report at this link: http://bit.ly/-ADMT-AnalystReport

About Small Cap Street
Once you read our reports written by our team of financial analysts you will understand that we make every effort to provide informative equity research reports for interested parties at no cost.
Our Financial Analysts spend countless hours researching stocks. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges. These reports include a straightforward assessment of the company by a financial analyst who has pledged to remain free of influence when writing research reports.

FORWARD-LOOKING DISCLAIMER

This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.
A full disclaimer can be found by viewing the full analyst report.

If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at editor@smallcapstreet.com. For any urgent concerns or inquiries please contact us at editor@smallcapstreet.com.
Source: Small Cap Street, LLC

Abattis Bioceuticals (CE) (USOTC:ATTBF)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024